The latest news regarding all matters of policy and public interest. This section contains releases regarding issues of government, international relations and trade, politics, education, economics, law, welfare, advocacy, and charity concerns. Learn about recent policy decisions as well as important campaigns, strategies, and protests in all areas of public interest. Also included are poll results, statistical information and announcements, and legal news.
WASHINGTON, Dec. 30, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS™ (tradipitant), an...
Average weight loss of ~17% if all patients stayed on treatment* with Wegovy® (semaglutide) tablets 25 mg (~14% regardless of if patients stayed on treatment**) in the OASIS 4 trial1 1.5 mg starting...
Break Wave represents the future of kidney stone treatment with the potential to become a first-line treatment option The Break Wave device non-invasively fragments stones in the kidney or ureter on...
Proliv™Rx therapy scales physician-directed brain neuromodulation beyond the clinic into the home CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused...
Grants of up to $600,000 are available to U.S.-based nonprofits and governmental organizations to help working adults navigate a fragmented learn-and-work ecosystem. WASHINGTON, Jan. 8, 2026...
Representing the largest recovery of this nature to date SAN FRANCISCO, Jan. 14, 2026 /PRNewswire/ -- Kaiser Permanente (Kaiser) has agreed to pay $556 million to resolve False Claims Act litigation...
Our free and easy-to-use journalist tools can help you stay on top of the best story ideas for your beat.
GET STARTED NOW
Reach the media, customers, and investors and achieve your communications goals by leveraging PR Newswire’s multichannel content distribution network and targeting tools.
LEARN MORE
